Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Virtual Advanced Course on Liquid Biopsy for Cancer Management 2021

ESMO-Virtual-Advanced-Course-on-Liquid-biopsy-1000x250
Start date
15 Jun 2021
End date
16 Jun 2021
Location
Virtual, CEST Time
Application deadline
17 May 2021

Please kindly note that the virtual course programme timings are to be considered CEST (Central European Summer Time).

Learning objectives

  • To understand the principles of blood-based liquid biopsies and the available methodologies for isolating tumor material from blood samples
  • To review and discuss data for liquid biopsy-based assessments as endpoints of antitumor activity in clinical trials
  • To understand the potential and limitations of liquid biopsy-based tumor genomic profiling for patient stratification and detection of predictive biomarkers of response to therapy
  • To learn how the assessment of tumor heterogeneity and evolution based on liquid biopsy assays can improve cancer treatment

Download the preliminary programme

Apply now!

How to apply

Application is via online form. During the application process you will be required to upload the following:

  • Your CV including a list of your publications

Application deadline

Application for the virtual course will close on Monday 17 May 2021.

Who can apply?

While this virtual course is primarily aimed at experienced oncologists resident in Europe, oncology clinical and research fellows, application is open to all ESMO members.

To apply, ESMO membership is mandatory. If you are not an ESMO member, or need to renew your membership, please visit the  ESMO membership pages.

What's included?

Successful applicants will benefit from complimentary registration for this virtual course.

Accreditation

The programme of this event has been accredited with 6 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to  ESMO-MORA Recertification Process & Requirements.

Co-Chairs

  • Joaquin Mateo, Spain
  • Ryan Corcoran, United States

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings